Sign in
4

Changes in Ownership

RxSight, Inc. Filed Acc 0000950170-24-012317

Chief Financial Officer sold 25,000 shares at an average $47.31 ($1,182,660)

  • Chief Financial Officer acquired 31,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thunen Shelley B Chief Financial Officer 2024-02-05 Option exercise +6,900 $4.34 $29,946 13,691 D
Thunen Shelley B Chief Financial Officer 2024-02-05 Option exercise +9,125 $14.95 $136,419 22,816 D
Thunen Shelley B Chief Financial Officer 2024-02-05 Sale −9,125 $47.02 $429,087 13,691 D
Thunen Shelley B Chief Financial Officer 2024-02-06 Option exercise +15,875 $14.95 $237,331 29,566 D
Thunen Shelley B Chief Financial Officer 2024-02-06 Sale −15,875 $47.47 $753,574 13,691 D
Derivatives
Thunen Shelley B Chief Financial Officer 2024-02-05 Option exercise · Stock Option (right to buy) −6,900 17,640 D
Thunen Shelley B Chief Financial Officer 2024-02-05 Option exercise · Stock Option (right to buy) −9,125 110,875 D
Thunen Shelley B Chief Financial Officer 2024-02-06 Option exercise · Stock Option (right to buy) −15,875 95,000 D
Open-market sales · 25,000 sh · avg $47.31 · $1,182,660
Loading xslF345X05/ownership.xml…